RecruitingNot ApplicableNCT06395935

Wecare Study in Gastric Cancer Survivors

A Multi-center, Prospective, Randomized Study to Evaluate the Usefulness of Applying the Chronic Side Effect Management Platform (Wecare) in Gastric Cancer Survivors

Sponsor

Gyeongsang National University Hospital

Enrollment

88 participants

Start Date

Apr 1, 2024

Study Type

INTERVENTIONAL

Conditions

Gastric Cancer

Summary

The KOrean QUality of life in Stomach cancer patients Study group (KOQUSS) made a method (KOQUSS-40) for assessing appropriately the quality of life of gastric cancer patients who have undergone gastrectomy, and developed a digital platform (Wecare) based on KOQUSS-40. In this study, we propose a randomized controlled trial to compare quality of life after gastrectomy in patients with and without smartphone app support.

Eligibility

Min Age: 19 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study follows gastric (stomach) cancer survivors after treatment to understand their long-term quality of life, nutritional needs, physical health, and emotional wellbeing — with the goal of improving survivorship care. **You may be eligible if...** - You have completed primary treatment (surgery, chemotherapy, radiation, or a combination) for gastric cancer - You are in remission or surveillance phase - You are at least 18 years old - You are willing to complete regular questionnaires and possibly provide samples **You may NOT be eligible if...** - You currently have active, uncontrolled gastric cancer - You have severe cognitive or communication difficulties - You are unable to consent or complete follow-up Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.